<DOC>
	<DOCNO>NCT01265875</DOCNO>
	<brief_summary>- To determine intravenous secretin administration escalate dos three time daily three day improve pain CP time infusion , infusion ( 1 3 hour ) , Day 7 infusion , Day 30 infusion . - To validate safety intravenous secretin administration dosage indicate study .</brief_summary>
	<brief_title>Secretin Infusion Pain Due Chronic Pancreatitis</brief_title>
	<detailed_description>12 patient enrol study . Patients treat Dartmouth-Hitchcock Medical Center diagnosis CP . The diagnosis CP make PI base standard clinical , radiographic and/or biochemical criterion . Patients must take prescribed opioid analgesic specific treatment CP time study enrollment . Only patient age 18-70 capable providing inform consent consider eligible study .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<mesh_term>Secretin</mesh_term>
	<criteria>1 . Male female , age 1870 year old . 2 . Documented chronic pancreatitis determine CT scan , endoscopic ultrasound , MRCP and/or pancreatic function test . 3 . If female , 1 year postmenopausal surgically sterile , must use medically acceptable form contraception abstain sexual activity study . Acceptable method birth control : intrauterine device , implantable progesterone device , progesterone intramuscular injection , oral contraceptive ( start least one month prior Screening Visit 1 continue duration trial ) , contraceptive patch , condom spermicide abstinence . 4 . If female reproductive potential , receive counsel pregnancy protection effective contraception within 30 day prior dose secretin . 5 . Negative serum pregnancy within 72 hour secretin administration . 6 . Use opioid analgesic chronic pain CP . 7 . Willing able sign write informed consent . 1 . Male female &lt; 18 &gt; 70 year age . 2 . Abnormal serum amylase and/or lipase indicative acute pancreatitis within 30 day study enrollment . 3 . Exhibiting sign and/or symptom episode acute pancreatitis . 4 . Severe cardiac disease ( stable unstable angina , congestive heart failure , uncontrolled arrhythmia , implantable defibrillator , severe valvular disease , etc ) . 5 . Severe pulmonary disease ( COPD , severe asthma , interstitial lung disease , etc ) . 6 . Severe renal disease ( history acute chronic renal failure , dialysis dependent , baseline creatinine &gt; 2.0 mg/dL ) . 7 . Previous adverse drug event intravenous secretin . 8 . Ongoing illicit drug use abuse . 9 . Ongoing moderate severe alcohol use define great 8 oz beer , 8 oz wine and/or 1 oz liquor /day . 10 . Acute pancreatitis define Atlanta Classification definition ( refer Table 1 ) within previous two month symptom consistent ongoing acute pancreatitis . 11 . Prior pancreatic surgery . 12 . Pregnant woman , nurse mother , woman childbearing potential employ appropriate contraception . 13 . Use medication potentially cause pancreatitis , metronidazole , tetracycline , sulfonamide within 30 day prior Visit 1 . 14 . Any medical condition , judgment investigator , render participation study medically inadvisable . 15 . Participation investigational clinical study drug medical device within 30 day prior Visit 1 . 16 . Unwilling unable give write , informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Chronic Pancreatitis</keyword>
</DOC>